Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NRXP
#4160
NRX Pharmaceuticals, Inc. Common Stock
2.550
0
USD
+1.59%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.59%
Monthly Change
+30.77%
6 month change
+43.26%
Year Change
+43.26%
Previous Close
2.510
0
Open
2.550
0
Bid
Ask
Low
2.550
0
High
2.550
0
Volume
63
Markets
US Stock Market
Healthcare
NRXP
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 25
Total assets
12.96 M
Total liabilities
28.89 M
Total equity
-15.94 M
Total liabilities & shareholders' equities
12.96 M
Total debt
0
Net debt
-7.8 M
News
NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates
NRx Pharmaceuticals, Inc. (NRXP) Shareholder/Analyst Call Prepared Remarks Transcript
NRx Pharmaceuticals receives FDA bioequivalence approval notice
NRx Pharmaceuticals receives FDA guidance on NRX-100 drug application
VTSAX vs. VTI: Which Vanguard Fund Should You Buy in 2026? - TipRanks.com
H.C. Wainwright raises NRx Pharmaceuticals stock price target to $45
NRx Pharmaceuticals appoints Joshua Brown as chief medical officer
NRx Builds Momentum From FDA Progress To Strategic Expansion - NRX Pharmaceuticals (NASDAQ:NRXP)
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26 - TipRanks.com
NRx Pharmaceuticals appoints Joseph M. Casper as chief operating officer
New Strong Sell Stocks for January 27th
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40